Molecular and Genetic Aspects of Lipid Metabolism Disorders and Potential Targets for Gene Therapy

Elvira R Akhmetzyanova1, Anna V Timofeeva1, Danil R Gallyamov1

  • 1OpenLab Gene and Cell Technology, Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.

Insights

Cardiovascular diseases linked to lipid metabolism disorders are a global health crisis. Gene therapy offers promising new strategies for treating these conditions by targeting underlying genetic and lifestyle factors.

Area of Science:

  • Biochemistry
  • Genetics
  • Cardiology

Background:

  • Cardiovascular diseases (CVDs) are a leading cause of global mortality and disability.
  • Impaired lipid metabolism, both primary (genetic) and secondary (lifestyle-induced), is a significant contributor to CVDs.
  • Understanding lipid metabolism pathways is crucial for developing effective therapeutic interventions.

Purpose of the Study:

  • To review potential therapeutic targets for lipid metabolism disorders.
  • To summarize current gene therapy approaches for treating lipid metabolism-related diseases.
  • To explore the future potential of gene therapy in managing cardiovascular disease.

Main Methods:

  • Literature review of studies on lipid metabolism, cardiovascular disease, and gene therapy.
  • Analysis of genetic factors and lifestyle influences on lipid metabolism.
  • Examination of existing and emerging gene therapy strategies.

Main Results:

  • Identification of key genes and pathways involved in lipid metabolism disorders.
  • Overview of various gene therapy techniques applicable to metabolic diseases.
  • Discussion of the potential of gene therapy to address both primary and secondary lipid disorders.

Conclusions:

  • Targeting lipid metabolism offers a viable strategy for CVD prevention and treatment.
  • Gene therapy presents a promising frontier for managing complex lipid metabolism disorders.
  • Further research and technological advancements in gene therapy are expected to expand treatment options for cardiovascular health.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...